Isabella Maria Mayer,Eszter Doma,Thorsten Klampfl,Michaela Prchal-Murphy,Sebastian Kollmann,Alessia Schirripa,Lisa Scheiblecker,Markus Zojer,Natalia Kunowska,Lea Gebrail,Lisa E Shaw,Ulrike Mann,Alex Farr,Reinhard Grausenburger,Gerwin Heller,Eva Zebedin-Brandl,Matthias Farlik,Marcos Malumbres,Veronika Sexl,Karoline Kollmann

Abstract:Inhibiting CDK6 kinase function enhances long-term HSC functionality Kinase-inactivated CDK6 and MAZ influence HSC maintenance Hematopoietic stem cells (HSCs) are characterized by the ability to self-renew and to replenish the hematopoietic system. The cell-cycle kinase cyclin dependent-kinase 6 (CDK6) regulates transcription, whereby it has both kinase-dependent and kinase-independent functions. We here describe the complex role of CDK6, balancing quiescence, proliferation, self-renewal and differentiation in activated HSCs. Mouse HSCs expressing kinase-inactivated CDK6 show enhanced long-term repopulation and homing, whereas HSCs lacking CDK6 have impaired functionality. The transcriptomes of basal and serially transplanted HSCs expressing kinase-inactivated CDK6 exhibit an expression pattern dominated by HSC quiescence and self-renewal, proposing a concept where MAZ and NFY-A are critical CDK6 interactors. Pharmacologic kinase inhibition with a clinically used CDK4/6 inhibitor in murine and human HSCs validated our findings and resulted in increased repopulation capability and enhanced stemness. Our findings highlight a kinase-independent role of CDK6 in long-term HSC functionality. CDK6 kinase inhibition represents a possible strategy to improve HSC fitness.

Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells